Skip to main content
. Author manuscript; available in PMC: 2014 Nov 15.
Published in final edited form as: Clin Cancer Res. 2013 Sep 16;19(22):6089–6100. doi: 10.1158/1078-0432.CCR-13-1116

Figure 1.

Figure 1

Pathway of in vitro to in vivo to Phase I/II/III clinical trials. Proposed model and activities of an International Consortium whereby potential drugs can be provided from academia, industry and government, and prioritized for evaluation through a ‘Steering Committee’.